company background image
LNTH

Lantheus Holdings NasdaqGM:LNTH Stock Report

Last Price

US$55.48

Market Cap

US$3.8b

7D

-8.5%

1Y

99.3%

Updated

06 Dec, 2022

Data

Company Financials +
LNTH fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance1/6
Financial Health6/6
Dividends0/6

LNTH Stock Overview

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.

Lantheus Holdings, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Lantheus Holdings
Historical stock prices
Current Share PriceUS$55.48
52 Week HighUS$87.47
52 Week LowUS$23.51
Beta0.72
1 Month Change-8.45%
3 Month Change-33.41%
1 Year Change99.28%
3 Year Change175.34%
5 Year Change170.63%
Change since IPO762.83%

Recent News & Updates

Recent updates

Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively

Oct 31
Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively

Does This Valuation Of Lantheus Holdings, Inc. (NASDAQ:LNTH) Imply Investors Are Overpaying?

Oct 04
Does This Valuation Of Lantheus Holdings, Inc. (NASDAQ:LNTH) Imply Investors Are Overpaying?

Lantheus Holdings (NASDAQ:LNTH) May Have Issues Allocating Its Capital

Jul 22
Lantheus Holdings (NASDAQ:LNTH) May Have Issues Allocating Its Capital

We Think Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt With Ease

Jun 25
We Think Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt With Ease

There Are Reasons To Feel Uneasy About Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital

Apr 22
There Are Reasons To Feel Uneasy About Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital

News Flash: Analysts Just Made A Sizeable Upgrade To Their Lantheus Holdings, Inc. (NASDAQ:LNTH) Forecasts

Mar 01
News Flash: Analysts Just Made A Sizeable Upgrade To Their Lantheus Holdings, Inc. (NASDAQ:LNTH) Forecasts

We Think Lantheus Holdings (NASDAQ:LNTH) Can Stay On Top Of Its Debt

Feb 13
We Think Lantheus Holdings (NASDAQ:LNTH) Can Stay On Top Of Its Debt

Returns On Capital At Lantheus Holdings (NASDAQ:LNTH) Paint A Concerning Picture

Jan 18
Returns On Capital At Lantheus Holdings (NASDAQ:LNTH) Paint A Concerning Picture

Would Lantheus Holdings (NASDAQ:LNTH) Be Better Off With Less Debt?

Nov 13
Would Lantheus Holdings (NASDAQ:LNTH) Be Better Off With Less Debt?

Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet?

Jul 28
Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet?

The Returns On Capital At Lantheus Holdings (NASDAQ:LNTH) Don't Inspire Confidence

May 19
The Returns On Capital At Lantheus Holdings (NASDAQ:LNTH) Don't Inspire Confidence

An Intrinsic Calculation For Lantheus Holdings, Inc. (NASDAQ:LNTH) Suggests It's 46% Undervalued

Apr 14
An Intrinsic Calculation For Lantheus Holdings, Inc. (NASDAQ:LNTH) Suggests It's 46% Undervalued

Imagine Holding Lantheus Holdings (NASDAQ:LNTH) Shares While The Price Zoomed 873% Higher

Mar 10
Imagine Holding Lantheus Holdings (NASDAQ:LNTH) Shares While The Price Zoomed 873% Higher

Here's What To Make Of Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital

Feb 08
Here's What To Make Of Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital

Shareholder Returns

LNTHUS Medical EquipmentUS Market
7D-8.5%1.9%1.1%
1Y99.3%-20.2%-17.6%

Return vs Industry: LNTH exceeded the US Medical Equipment industry which returned -20.2% over the past year.

Return vs Market: LNTH exceeded the US Market which returned -17.6% over the past year.

Price Volatility

Is LNTH's price volatile compared to industry and market?
LNTH volatility
LNTH Average Weekly Movement8.5%
Medical Equipment Industry Average Movement8.9%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: LNTH is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: LNTH's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1956612Mary Heinohttps://www.lantheus.com

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer.

Lantheus Holdings, Inc. Fundamentals Summary

How do Lantheus Holdings's earnings and revenue compare to its market cap?
LNTH fundamental statistics
Market CapUS$3.82b
Earnings (TTM)US$107.04m
Revenue (TTM)US$801.46m

35.7x

P/E Ratio

4.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
LNTH income statement (TTM)
RevenueUS$801.46m
Cost of RevenueUS$329.02m
Gross ProfitUS$472.44m
Other ExpensesUS$365.40m
EarningsUS$107.04m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.56
Gross Margin58.95%
Net Profit Margin13.36%
Debt/Equity Ratio26.2%

How did LNTH perform over the long term?

See historical performance and comparison